Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cyclerion Therapeutics Reports Q1 Net Loss Of $(7.0)M Vs $(13.0)M Last Year

Author: Benzinga Newsdesk | May 11, 2023 06:07pm

Net loss was approximately $(7.0) million for Q1 2023, as compared to approximately $(13.0) million for Q1 2022.

Posted In: CYCN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist